Company: MBIO
Filing Date: 2025-01-10
Form Type: PRE 14C
Source: 0001104659-25-002602
Chunk: 2

Company: MUSTANG BIO, INC.
Filing Date: 2025-01-10
Form: PRE 14C
Chunk 2
---
 at the close of business on January 10, 2025 (the
“Record Date”) of the shares of common stock, par value $0.0001 per share, of Mustang Bio, Inc., a Delaware corporation (“Mustang,”
“we,” “our,” “us,” or the “Company”), in connection with the actions taken by written
consent of the Majority Holders in lieu of a meeting to approve the actions described in this Information Statement.

The Majority Holders, beneficially owning 6,552,781 shares of our issued and outstanding common stock and 250,000 shares of our issued and outstanding Class A Preferred Stock, have executed the Written Consent approving the Warrant ShareIssuance. The Majority Holders
held of record on the Record Date approximately 57% of the voting power necessary to approve the proposed Warrant Share Issuance. Dissenting
stockholders do not have any statutory appraisal rights as a result of the actions taken. The Board does not intend to solicit any proxies
or consents from any other stockholders in connection with this action. All necessary corporate approvals have been obtained, and this
Information Statement is furnished solely to advise stockholders of the action taken by the Written Consent.

Section 228 of the DGCL generally
provides in substance that unless a company’s certificate of incorporation provides otherwise, stockholders may take any action
without a meeting of stockholders, without prior notice and without a vote if a consent or consents in writing, setting forth the action
so taken, is signed by holders of the outstanding stock having not less than the minimum number of votes that would be necessary to authorize
and take such action at a meeting at which all shares entitled to vote thereon were present voted. In order to eliminate the costs and
management time involved in obtaining proxies and to effect the above action as early as possible in order to accomplish the purposes
of the Company as herein described, the Board determined to pursue stockholder action by written consent and successfully obtained written
consent of the Majority Holders.

This Information Statement is being distributed pursuant to the requirements of the Exchange Act to our stockholders of record on the Record Date. The Warrant Share Issuance will not become effective before the date which is 20 days after this Information Statement is first mailed to our stockholders. The 20-day period is expected to conclude on or about , 2025.

The entire cost of furnishing
this Information Statement will be borne by the Company. We